The protective efficacy of Celgene's candidate compounds CC-11050 and CC-5048 against Ebola virus in guinea pigs

Project: Other project

StatusFinished
Effective start/end date7/1/118/30/12

Funding

  • Celgene Corporation: $47,954.00